<DOC>
	<DOCNO>NCT01086059</DOCNO>
	<brief_summary>The purpose OTIS Autoimmune disease pregnancy study monitor plan unplanned pregnancy expose certain medication , evaluate possible teratogenic effect medication follow live born infant one year birth . With respect fetal outcome , important evaluate spectrum outcome may relevant medication exposure pregnancy , include easily recognizable defect visible birth , well , subtle delay defect may readily identifiable without special expertise observation beyond newborn period .</brief_summary>
	<brief_title>OTIS Autoimmune Diseases Pregnancy Project</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Currently pregnant</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Autoimmune disease</keyword>
	<keyword>adalimumab</keyword>
	<keyword>pregnancy</keyword>
	<keyword>birth defect</keyword>
	<keyword>TNF</keyword>
	<keyword>Tumor necrosis factor</keyword>
</DOC>